Lantis believes that OCT will provide dentists with an unprecedented level of image resolution to assist in the evaluation of periodontal disease, dental restorations and in the detection of caries.

OCT imaging was invented by Professor James Fujimoto, Eric Swanson and their colleagues at MIT. The first medical application resulting from this work, ophthalmology, is licensed to Humphrey Instruments, which is a subsidiary of Carl Zeiss, Inc. The product, introduced to the market in 1996, is currently used to diagnose macular degeneration, an incurable eye disease that is the leading cause of blindness for those aged 55 and older in the United States. Macular degeneration affects more than 10 million Americans.

In 2000, Asahi Optical Company, Ltd. and LightLab Imaging announced a product development alliance with the goal of providing gastroenterologists a new class of high-resolution endoscopic imaging technology utilizing OCT. Under the terms of the agreement, the Pentax Medical Instrument Division of Asahi Optical Company gained access to LightLab Imaging's intellectual property and proprietary optical probe technology for endoscopic Optical Coherence Tomography. The two companies are co-developing intraluminal OCT systems for gastrointestinal and pulmonary applications.

In 2001, LightLab Imaging and Lantis Laser, Inc., announced a licensing agreement related to the use of Optical Coherence Tomography in the field of dentistry. Under the terms of the agreement, Lantis Laser gained license to LightLab Imaging's intellectual property portfolio related to OCT in the field of dentistry. Lantis believes that OCT will provide dentists with an unprecedented level of image resolution to assist in the evaluation of periodontal disease, dental restorations and in the detection of caries.